Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

National Survey Shows 1 In 10 Children Use Cough/Cold OTCs Each Week

This article was originally published in The Tan Sheet

Executive Summary

A long-term study underscores possible risks from OTC pediatric cough/cold products and emphasizes the significance of FDA's ongoing review of the medicines' safety and efficacy for 2- to 11-year-old children
Advertisement

Related Content

Pediatric Cough/Cold “Reverse Switch” Will Not Increase Safety – CHPA
Pediatric Cough/Cold “Reverse Switch” Will Not Increase Safety – CHPA
Pediatric Cough/Cold “Reverse Switch” Will Not Increase Safety – CHPA
FDA Call For Pediatric Cough/Cold Input Signals New Rule Is A Long Way Off
Umbrella Brands Help Identify “Known And Trusted” Products – CHPA
Child-Resistant Packaging In The Works For More OTC Cold Products – CHPA
FDA Working Group Considering Changes To OTC Cough/Cold Monograph
FDA Working Group Considering Changes To OTC Cough/Cold Monograph
CHPA Rolls Out Pediatric Cough/Cold Education Campaign
FDA Panel Narrowly Votes Against Cough/Cold Drugs For Children Up To Age 6

Topics

Advertisement
UsernamePublicRestriction

Register

PS101981

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel